Managing IP survey: SPC framework

Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX

Copyright © Legal Benchmarking Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Managing IP survey: SPC framework

biotech168

Managing IP is seeking views from in-house counsel at pharma and biotech companies on the state of the SPC framework in Europe; including Article 3a, the waiver and unitary SPCs

biotech200

You can take the survey here

Please only take the survey if you are an in-house lawyer from a pharmaceutical, biotech or life sciences company.


We are looking to gain and share insight on how in-house IP counsel view the SPC framework in Europe; including Article 3a, the SPC Manufacturing Waiver and unitary SPCs. 

This is the second in our series of in-house surveys in 2019. You can read the special report on the findings of that survey, on the changing dynamic between artificial intelligence and IP, here.

Don’t miss the chance to have your say.

The survey should take no longer than five minutes to complete, and all responses will only be published in an aggregated and anonymised form. The more responses we get, the more illuminating the final report will be.

If you would like to discuss your thoughts in more detail, please contact Patrick Wingrove at patrick.wingrove@managingip.com

more from across site and ros bottom lb

More from across our site

Firms that advise generics businesses reflect on whether they’re seeing more aggressive tactics from innovators and how they’re managing their practices
Suspicions concerning AI in the legal space, and another copyright win for Ed Sheeran were among the biggest IP developments this week
Michael Sitzman, a life sciences litigator, explains how McDermott’s busy schedule at the UPC convinced him to join
The UK’s top court will hand down the decision next week, 17 months after hearing arguments in the crucial trademark dispute
Ceyda Maisami explains why HP is becoming more vocal in its SEP arguments and reveals why the company has transformed the way it engages with outside counsel
In the latest UPC update, we examine a ruling on director liability, another on the Gillette defence, and look ahead to cases concerning medical devices
Burak Yüceel outlines six characteristics that make a successful IP practitioner and explains why Alan Turing is an inspiration
Lawyers at Dentons unpick the findings of a survey that revealed that businesses tend to focus on reactive rather than proactive use of AI when performing IP evaluations
Peng Lei and David Webb of Herbert Smith Freehills assess what battery innovators need to know to protect their investments
Little to no policies from either candidate suggest we may be waiting a while before we see major changes to the US’s IP framework
Gift this article